{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T23:35:39Z","timestamp":1773617739938,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.annder.2022.11.005","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T08:25:31Z","timestamp":1673598331000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic inertia during isotretinoin treatment of juvenile acne by dermatologists, paediatricians and general practitioners"],"prefix":"10.1016","volume":"150","author":[{"given":"E.","family":"Mah\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Salinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guellich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Maruani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Assathiany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2022.11.005_b0005","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.2021.17633","article-title":"Management of Acne Vulgaris: A Review","volume":"326","author":"Eichenfield","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2022.11.005_b0010","first-page":"97","article-title":"Prevalence and Risk Factors of Acne Scarring Among Patients Consulting Dermatologists in the USA","volume":"16","author":"Tan","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2022.11.005_b0015","doi-asserted-by":"crossref","first-page":"adv00175","DOI":"10.2340\/00015555-3531","article-title":"Psychological Consequences of the Most Common Dermatoses: Data from the Objectifs Peau Study","volume":"100","author":"Misery","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.annder.2012.06.039","article-title":"Enqu\u00eate sur la prise en charge des patients acn\u00e9iques en France","volume":"139","author":"Seit\u00e9","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mjd.2001.115965","article-title":"A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne","volume":"45","author":"Strauss","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2022.11.005_b0030","doi-asserted-by":"crossref","first-page":"e15109","DOI":"10.1111\/dth.15109","article-title":"Investigation of relapse rate and factors affecting relapse after oral isotretinoin treatment in patients with acne vulgaris","volume":"34","author":"Demirci","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2022.11.005_b0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.annder.2015.09.004","article-title":"Prise en charge de l'acn\u00e9. Traitement de l'acn\u00e9 par voie locale et g\u00e9n\u00e9rale","volume":"142","author":"Le Cleach","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0040","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/jdv.16430","article-title":"Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin","volume":"34","author":"Dessinioti","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40257-020-00508-0","article-title":"Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes","volume":"21","author":"Landis","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.annder.2022.11.005_b0050","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jdv.16005","article-title":"Isotretinoin and risk factors for suicide attempt: a population-based comprehensive case series and nested case-control study using 2010\u20132014 French Health Insurance Data","volume":"34","author":"Droitcourt","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/jid.2010.264","article-title":"Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study","volume":"131","author":"Halvorsen","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2022.11.005_b0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/ced.15039","article-title":"First use of the Adolescent Depression Rating Scale (ADRS) in the management of young people with severe acne treated with isotretinoin: a pilot study of an active monitoring of depressive disorders by dermatologists","volume":"47","author":"Hefez","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2022.11.005_b0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.annder.2011.11.012","article-title":"Isotr\u00e9tino\u00efne et d\u00e9pression \u00e0 l'adolescence","volume":"139","author":"Misery","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2515\/therapie\/2015026","article-title":"Drug-induced Depression: a Case\/Non Case Study in the French Pharmacovigilance Database","volume":"70","author":"Lafay-Chebassier","year":"2015","journal-title":"Therapie"},{"issue":"Suppl 2","key":"10.1016\/j.annder.2022.11.005_b0075","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0151-9638(10)70030-2","article-title":"Isotr\u00e9tino\u00efne et d\u00e9pression: un sujet m\u00e9diatis\u00e9","volume":"137","author":"Wolkenstein","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0080","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1067\/mjd.2001.118233","article-title":"Suicide, depression, and isotretinoin: is there a causal link?","volume":"45","author":"Jacobs","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2022.11.005_b0085","unstructured":"ANSM. Traitement de l\u2019acn\u00e9 s\u00e9v\u00e8re : premi\u00e8res recommandations pour am\u00e9liorer la s\u00e9curit\u00e9 d\u2019utilisation de l\u2019isotr\u00e9tino\u00efne. 2021. Available at: https:\/\/ansm.sante.fr\/actualites\/traitement-de-lacne-severe-premieres-recommandations-pour-ameliorer-la-securite-dutilisation-de-lisotretinoine."},{"key":"10.1016\/j.annder.2022.11.005_b0090","unstructured":"ANSM. Etude des prescriptions d'isotr\u00e9tino\u00efne orale en France. P\u00e9riode 2007 \u2013 2013. Avalable at: https:\/\/archiveansm.integra.fr\/var\/ansm_site\/storage\/original\/application\/9af2d137d2a58cc7cb3d38815aebd5fd.pdf."},{"key":"10.1016\/j.annder.2022.11.005_b0095","first-page":"34","article-title":"Usage and equity of access to isotretinoin in New Zealand by deprivation and ethnicity","volume":"124","author":"Moodie","year":"2011","journal-title":"N Z Med J"},{"key":"10.1016\/j.annder.2022.11.005_b0100","doi-asserted-by":"crossref","first-page":"e0210445","DOI":"10.1371\/journal.pone.0210445","article-title":"Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era","volume":"14","author":"Charrow","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2022.11.005_b0105","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","article-title":"Clinical inertia","volume":"135","author":"Phillips","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2022.11.005_b0110","first-page":"232","article-title":"Inertie th\u00e9rapeutique dans la pratique m\u00e9dicale : causes, cons\u00e9quences, solutions","volume":"65","author":"Scheen","year":"2010","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.annder.2022.11.005_b0115","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s12325-018-0819-5","article-title":"Addressing clinical inertia in type 2 diabetes mellitus: a review","volume":"35","author":"Okemah","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.annder.2022.11.005_b0120","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fneur.2018.00781","article-title":"Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists","volume":"9","author":"Saposnik","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.annder.2022.11.005_b0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11906-018-0802-1","article-title":"Therapeutic Inertia and Treatment Intensification","volume":"20","author":"Josiah Willock","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.annder.2022.11.005_b0130","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/ijd.14914","article-title":"Perception of therapeutic inertia by patients with psoriasis in France","volume":"59","author":"Halioua","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2022.11.005_b0135","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/jdv.15882","article-title":"Therapeutic inertia in the management of moderate-to-severe plaque psoriasis","volume":"34","author":"Halioua","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0140","doi-asserted-by":"crossref","first-page":"adv00475","DOI":"10.2340\/00015555-3813","article-title":"Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents","volume":"101","author":"Melin","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2022.11.005_b0145","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie. Traitement de l\u2019acn\u00e9 par voie locale et g\u00e9n\u00e9rale. Argumentaire scientifique. 2015. Available at: https:\/\/www.sfdermato.org\/upload\/recommandations\/label-argumentaire-acne-post-ollege-54ac60356d1b9584a71ccaac92cf3724.pdf."},{"key":"10.1016\/j.annder.2022.11.005_b0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.arcped.2015.11.019","article-title":"Prise en charge de l'acn\u00e9. Traitement de l'acn\u00e9 par voie locale et g\u00e9n\u00e9rale","volume":"23","author":"Le Cleach","year":"2016","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.annder.2022.11.005_b0155","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/bjd.15843","article-title":"Guidelines for the management of acne: recommendations from a French multidisciplinary group","volume":"177","author":"Le Cleach","year":"2017","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963822001193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963822001193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:11:06Z","timestamp":1758971466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963822001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0151963822001193"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2022.11.005","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic inertia during isotretinoin treatment of juvenile acne by dermatologists, paediatricians and general practitioners","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}